Placebo-controlled trial of naftazone in women with primary uncomplicated symptomatic varicose veins

Phlebology

Volumn 12, Issue 1, 1997, Pages 17-20

  Vayssairat, M ^a   Aubin, B ^a   Badina, B ^a   Brun, M ^a   Custoza, E ^a   Dandine, P ^a   Dessirier, B ^a   Dubois, N ^a   Duc Mauger, C ^a   Elbhar, C ^a   Fauvel, G ^a   Fouquaut, J ^a   Fredenucci, P ^a   Frey, J L ^a   Garcia Laffont, P ^a   Gerard, P ^a   Gillet, J L ^a   Gobin, J P ^a   Hessman, J ^a   Hiltbrand, B ^a   Hirsh, D ^a   Iscovici, X ^a   Knauer, V ^a   Laffont, J G ^a   Lampel, M ^a   Le Duff, M ^a   Lequentrec, P ^a   Maillan Martin, M ^a   Mollard, J M ^a   Morzol, B ^a   Paillard, C ^a   Pelissier, J ^a   Pichot, O ^a   Pintat Ferrer, F ^a   Prat, O ^a   Robillot, J J ^a   Tenailleau, A ^a   more..

^a HÔPITAL TENON   (France)

Author keywords

Pharmacological treatment; Superficial venous insufficiency; Varicose veins; Venoactive drug

Indexed keywords

HEMOSTATIC AGENT; NAFTAZONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FRANCE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VARICOSIS; VEIN INSUFFICIENCY;

EID: 9844225605     PISSN: 02683555     EISSN: None     Source Type: Journal    
DOI: 10.1177/026835559701200103     Document Type: Article

References (15)

1. Anonymous. The treatment of varicose veins. Lancet 1975; ii:311-2.
2. Coleridge Smith PD. Pharmacological treatment for venous disease. Phlebology 1994;9:47.
3. Gilly R, Pillion G, Frileux C. Evaluation of a new venoactive micronized flavonoid fraction (S 5682) in symptomatic disturbances of the venolymphatic circulation of the lower limb: a double-blind, placebo-controlled study. Phlebology 1994;9:67-70.
4. Vin F, Chabanel A, Taccoen A, et al. Double-blind trial of the efficacy of Troxerutin in chronic venous insufficiency. Phlebology 1994;9:71-6.
5. Diehm C, Trampish HJ, Lange S, Schmidt C. Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet 1996; 347:292-4.
6. Porter JM, Rutherford RB, Clagett GP, et al. Subcommittee on Reporting Standards in Venous Disease. J Vasc Surg 1988;8:172-81.
7. Huskisson EC. Measurement of pain. Lancet 1974;ii:1127-31.
8. Vayssairat M, Maurel A, Gouny P, Baudot N, Gaitz JP, Nussaume O. La volumétrie: une méthode précise de quantification en phlébologie. J Mal Vase 1994;19:108-10.
9. Osmundson PJ, O'Fallon M, Clements IP, Kazmier FJ, Zimmerman BR, Palumbo PJ. Reproducibility of non-invasive tests of peripheral occlusive disease. J Vasc Surg 1985;2:678-83.
10. Pulvertaft TB. General practice treatment of symptoms of venous insufficiency with oxerutins. Results of a 660 patient multicentre study in the UK. Vasa 1983, 12:373-6.
11. Klein-Soyer C, Bloy C, Archipoff G, Beretz A, Cazenave JP. Naftazone accelerates human saphenous vein endothelial cell proliferation in vitro. Nouv Rev Fr Hematol 1995;37:187-92.
12. Bloy C, Bach S, Secchi J. Action de la Naftazone (Etioven) sur la cellule endothéliale de la veine saphène humaine en hypoxie. J Mal Vase 1995;20 (Suppl A): 42-3 (abstr.).
13. Roztocil K, Prerovsky I, Oliva I. The effect of hydroxyethylrutosides on capillary filtration rate in the lower limb of man. Eur J Clin Pharmacol 1977;11:435-8.
14. Behar A, Nathan P, Lavieuville M, Allaert FA. Effet du veinotonyl 75 sur le test de perméabilité capillaire à l'albumine technétiée dans les oedèmes cycliques orthostatiques. Phlébologie 1993; 46:721-31.
15. Parving HH, Worm AM, Rossing N. Plasma volume, intravascular albumin and its transcapillary escape rate in patients with extensive skin disease. Br J Dermatol 1976;95:519-24.